Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0137 EUR | -3,52% | -12,18% | -77,61% |
11/04 | BioSenic dient herstructureringsplan in | AM |
20/03 | BioSenic presenteert succesvolle studiedata op het Systemic Sclerosis World Congress 2024 | AM |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 2,51 mln. 2,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -5 mln. -5,38 mln. | Nettowinst (verlies) 2024 * | -11 mln. -11,84 mln. | EV/omzet 2023 * | - |
Nettoschuld 2023 * | 18,8 mln. 20,23 mln. | Nettoschuld 2024 * | 29,3 mln. 31,53 mln. | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,27
x | K/w-verhouding 2024 * |
-0,15
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 73,22% |
1 dag | -3,52% | ||
1 week | -12,18% | ||
Lopende maand | -7,43% | ||
1 maand | -45,85% | ||
3 maanden | -66,59% | ||
6 maanden | -74,15% | ||
Lopend jaar | -77,61% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 03-04-23 |
Nicco Carole
COO | Chief Operating Officer | - | 18-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-05-24 | 0,0137 | -3,52% | 594 190 |
02-05-24 | 0,0142 | -4,05% | 1 241 022 |
30-04-24 | 0,0148 | -5,13% | 1 242 886 |
29-04-24 | 0,0156 | 0,00% | 851 085 |
26-04-24 | 0,0156 | -4,29% | 880 789 |
Real Time Euronext Bruxelles, 03 mei 2024 om 17:22 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-77,61% | 2,71 mln. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |